SCHEMBL6442704

SCHEMBL6442704

O=S(=O)(O)c1ccc2c(c1)C=CCN2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
HSD17B10 Q99714 4/20 0.36
CA1 P00915 4/20 0.36
CA2 P00918 4/20 0.36
CA12 O43570 3/20 0.36
CA7 P43166 2/20 0.36
CA14 Q9ULX7 2/20 0.36
LMNA P02545 1/20 0.34
TSHR P16473 3/20 0.33
TDP1 Q9NUW8 3/20 0.33
NT5E P21589 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
CASP6 P55212 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.31
SNCA P37840 2/20 0.31
ING2 Q9H160 1/20 0.31
PARP1 P09874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30506090 0.83 CA1 (0.46) ALDH1A1CA1CA2CA12CA7
SCHEMBL4708426 0.83 CA1 (0.46) ALDH1A1CA1CA2CA12CA7
SCHEMBL3503657 0.70 CYP2A6 (0.38) ALDH1A1HSD17B10TSHRTDP1KDM4E
SCHEMBL8470839 0.70 CA9 (0.46) ALDH1A1HSD17B10CA1CA12LMNA
SCHEMBL4145462 0.69 ALDH1A1 (0.41) ALDH1A1HSD17B10CA1CA2CA12
SCHEMBL1257327 0.69 AHR (0.35) ALDH1A1HSD17B10TSHRTDP1PARP1
SCHEMBL30695309 0.69 HTR5A (0.33) CYP2C19PARP1KMT2A
SCHEMBL17979435 0.68
SCHEMBL30311540 0.67 CA1 (0.46) ALDH1A1HSD17B10CA1CA2CA12
SCHEMBL27052187 0.67 CA1 (0.46) ALDH1A1HSD17B10CA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3008057-A1 BICYCLIC SULFONAMIDE COMPOUNDS AS SODIUM CHANNEL INHIBITORS Amgen Inc. (US) 2016-04-20 EP disclosed
WO-2014201206-A1 BICYCLIC SULFONAMIDE COMPOUNDS AS SODIUM CHANNEL INHIBITORS AMGEN INC. (US) 2014-12-18 WO disclosed
EP-1608643-A1 6-SULFONAMIDE QUINOLINE AND CHROMENE DERIVATIVE AS ANDROGEN RECEPTOR ANTAGONISTS Warner-Lambert Company LLC (US) 2005-12-28 EP disclosed
WO-2004083204-A1 6-SULFONAMIDE QUINOLINE AND CHROMENE DERIVATIVE AS ANDROGEN RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY LLC (US) 2004-09-30 WO disclosed